Work

Abstract P6-04-05: ERX-41, a novel drug to target and block mutant-ERα-coregulator driven signaling

Year: 2020

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs19-p6-04-05

Authors: Ratna Vadlamudi, Suryavathi Viswanadhapalli, Xihui Liu, Tae-Kyung Lee, Gangadhara R Sareddy, Shihong Ma, Mengxing Li, Ben Ho Park, Rajeshwar R Tekmal, Jung-Mo Ahn, Ganesh V. Raj

Institutions: The University of Texas at San Antonio Health Science Center, The University of Texas Southwestern Medical Center, Vanderbilt-Ingram Cancer Center

Language: English

Topic: Estrogen and related hormone effects

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3013615722

Cites:

Cited by:

Related to: 10